Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • January–March 2024
ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain
by Edson Silva-Filho, PhD, and Rodrigo Pegado, PhD Both authors are with Graduate Program in Heath Science, Graduate Program in Physical Therapy, Federal University of Rio Grande do Norte in Rio Grande do Norte, Brazil. [...]
Genesis of Mental Disorders: Could It Be Cavum Septum Pellucidum (CSP) et Vergae? A Case Report of CSP in Schizophrenia with Catatonia
by Allison Zuckerberg, MD; Nitin Pothen, MD; and Adriana Fitzsimmons, MD Dr. Zuckerberg is with Department of Psychiatry, Temple University Hospital in Philadelphia, Pennsylvania. Dr. Pothen is with Department of Psychiatry, Ocean University Medical Center [...]
Risk Management: Blurring the Lines—Boundary Violation
by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee [...]
Letter to the Editor: Whether Telerehabilitation is Actually Beneficial in Iatrogenic Facial Palsy Needs to be Confirmed by Prospective, Multicenter, Controlled Studies
Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(10–12):8. Dear Editor: We read with [...]
Left Ventricular Noncompaction Cardiomyopathy Diagnosis in a Patient Presenting with Epileptic Seizure: A “Double-edged Sword”
by Eirini Beneki, MD, MSc, PhD; Kyriakos Dimitriadis, MD, PhD; Konstantinos Tsatiris, MD, MSc; Konstantina Aggeli, MD, PhD; and Konstantinos Tsioufis, MD, PhD Drs. Beneki, Dimitriadis, Aggeli, and Tsioufis are with First Cardiology Department, School [...]
Outpatient Pharmacogenomic Screenings to Prevent Addiction, Overdose, and Suicide
by Atmaram Yarlagadda, MD; Kevin Swift, PhD; Nabarun Chakraborty, MS, MBA; Rasha Hammamieh, PhD; Amina Abubakar, PharmD; Marianna Wilbur, PharmD; and Anita H. Clayton, MD Dr. Yarlagadda is Installation Director of Psychological Health at McDonald [...]
Impact of COVID-19 on the Mental Health of Psychiatric Inpatients
by Samara White, PharmD; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Eileen Trigoboff, PMHCNS-BC, DNS, DABFN; Lucy Keers, PharmD; and Chloe Matecki, PharmD All authors are with Department of Pharmacy Practice, State University of [...]
Impact of the Medication Shortages on Psychiatric Patients: Exploring the Consequences of Lorazepam Injection Scarcity
by Yael Marks, BS, PharmD; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; and Chloe Matecki, PharmD All authors are with Department of Pharmacy Practice, State University of New York at Buffalo, School of Pharmacy [...]
Past Articles
Remote Cognitive Therapeutic Exercise in Facial Nerve Palsy Rehabilitation: Pandemic Tips and Tricks
by Filippo Cavallaro, PT; Simona Portaro, MD, PhD; Teresa Pintaudi, PT; Mariachiara Ceccio, PT; and Angelo Alito, MD All authors are with the University of Messina in Messina, Italy. Funding: No funding was provided for [...]
Special Challenges in Pediatric Drug Development: First of Three Sets of Expanded Proceedings from the ISCTM Autumn Conference on Pediatric Drug Development
by Philip D. Harvey, PhD; Joan Busner, PhD; Gahan Pandina, PhD; H. Gerry Taylor, PhD; Meg Grabb, PhD; and Joohi Jimenez-Shahed, MD Dr. Harvey is with Department of Psychiatry, University of Miami Miller School of [...]
Implications of Pediatric Initiatives on CNS Drug Development for All Ages—2020 and Beyond: Second of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development
by Gahan Pandina, PhD; Joan Busner, PhD; Joseph P. Horrigan, MD; Christine McSherry, RN, BSN; Alison Bateman-House, MA, MPH, PhD; Luca Pani, MD; and Judith Kando, PharmD, BCPP Dr. Pandina is with Janssen Pharmaceuticals in Titusville, [...]
Patient Centricity: Design and Conduct of Clinical Trials in Orphan Diseases: Third of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development
by Joan Busner, PhD; Gahan Pandina, PhD; Simon Day, PhD; Atul Mahableshwarkar, MD; Lucas Kempf, MD; Maria Sheean, MD; and Judith Dunn, PhD Dr. Busner is with Signant Health in Blue Bell, Pennsylvania and Department of Psychiatry, [...]
Exploring the Impact of COVID-19 Vaccination on Patients Taking Clozapine
by Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Carolyn O’Donnell, PharmD, PGY-2 Drs. Demler and O’Donnell are with the New York State Office of Mental Health at Buffalo Psychiatric Center and State University of New [...]
WAVES: A Novel Test to Evaluate Visuospatial Construction Ability in a School-aged Population
by Franco Di Cesare, MD; Cristiana Di Carlo, MSc; and Leonardo Di Cesare, MD Drs. F. Di Cesare and Di Carlo are with Leoben Research srl in Rome, Italy. Dr. L. Di Cesare is with Glaxo-Smith-Kline [...]
Development of a Symbol Cancellation Test to Evaluate Attention in a School-aged Zambian Population
by Franco Di Cesare, MD; Cristiana Di Carlo, MSc; and Leonardo Di Cesare, MD Drs. F. Di Cesare and Di Carlo are with Leoben Research srl in Rome, Italy. Dr. L. Di Cesare is with Glaxo-Smith-Kline [...]
Depersonalization/Derealization Disorder and Neural Correlates of Trauma-related Pathology: A Critical Review
by Rachael J. Murphy, MD Dr. Murphy is with the Department of Psychiatry at Lehigh Valley Health Network in Bethlehem, Pennsylvania. Funding: No funding was provided for this article Disclosures: The author has no conflicts [...]